Saied M Soliman1, Raghdaa A Massoud1, Hessa H Al-Rasheed2, Ayman El-Faham1,2. 1. Department of Chemistry, Faculty of Science, Alexandria University, P.O. Box 426, Ibrahimia, Alexandria 21321, Egypt. 2. Department of Chemistry, College of Science, King Saud University, P.O. Box 2455, Riyadh 11451, Saudi Arabia.
Abstract
Two penta-coordinated [Co(MorphBPT)Cl2]; 1 and [Co(PipBPT)Cl2]; 2 complexes with the bis-pyrazolyl-s-triazine pincer ligands MorphBPT and PipBPT were synthesized and characterized. Both MorphBPT and PipBPT act as NNN-tridentate pincer chelates coordinating the Co(II) center with one short Co-N(s-triazine) and two longer Co-N(pyrazole) bonds. The coordination number of Co(II) is five in both complexes, and the geometry around Co(II) ion is a distorted square pyramidal in 1, while 2 shows more distortion. In both complexes, the packing is dominated by Cl…H, C-H…π, and Cl…C (anion-π stacking) interactions in addition to O…H interactions, which are found only in 1. The UV-Vis spectral band at 564 nm was assigned to metal-ligand charge transfer transitions based on TD-DFT calculations. Complexes 1 and 2 showed higher antimicrobial activity compared to the respective free ligand MorphBPT and PipBPT, which were not active. MIC values indicated that 2 had better activity against S. aureus, B. subtilis, and P. vulgaris than 1. DPPH free radical scavenging assay revealed that all the studied compounds showed weak to moderate antioxidant activity where the nature of the substituent at the s-triazine core has a significant impact on the antioxidant activity.
Two penta-coordinated [Co(MorphBPT)Cl2]; 1 and [Co(PipBPT)Cl2]; 2 complexes with the bis-pyrazolyl-s-triazine pincer ligands MorphBPT and PipBPT were synthesized and characterized. Both MorphBPT and PipBPT act as NNN-tridentate pincer chelates coordinating the Co(II)center with one short Co-N(s-triazine) and two longer Co-N(pyrazole) bonds. The coordination number of Co(II) is five in both complexes, and the geometry around Co(II) ion is a distorted square pyramidal in 1, while 2 shows more distortion. In both complexes, the packing is dominated by Cl…H, C-H…π, and Cl…C (anion-π stacking) interactions in addition to O…H interactions, which are found only in 1. The UV-Vis spectral band at 564 nm was assigned to metal-ligand charge transfer transitions based on TD-DFT calculations. Complexes 1 and 2 showed higher antimicrobial activity compared to the respective free ligand MorphBPT and PipBPT, which were not active. MIC values indicated that 2 had better activity against S. aureus, B. subtilis, and P. vulgaris than 1. DPPH free radical scavenging assay revealed that all the studied compounds showed weak to moderate antioxidant activity where the nature of the substituent at the s-triazinecore has a significant impact on the antioxidant activity.
Triazine is a prototypal molecule that has, together with its derivatives, a wide commercial uses, for example, in resins, dyes, herbicides, or as sulfide removal agents [1,2]. These compounds are a well-suited model system in molecular imprinting [3]. s-Triazines are widely used within the pharmaceutical, textile, plastic, and rubber industries, and as pesticides, dyestuffs, optical bleaches, explosives, and surface-active agents [4,5,6]. s-Triazine and its compounds are also used as subunits in the formation of supramolecular structures because they possess good optical and electronic properties and are able to form three strong hydrogen bonds with the host molecule [7].On the other hand, bacterial and fungalinfectious diseases are very common all over the world. Due to the rapid development in drug resistance, tolerance, and side effects, there is a critical need for new antibacterial and antifungal agents that exhibit improved pharmacological properties and drug-resistance profiles [8,9]. In this aspect, the triazineclass [10,11,12,13,14,15,16,17,18,19] and their metalcomplexes [20,21,22,23,24] have been received a great deal of attention as they demonstrate wide range of therapeutic activities and a great array of biological applications including antimicrobial, antituberculosis, anticancer, antiviral, antibacterial, antifungal, anti-HIV, and antimalarial activities [9,25,26]. In addition, a number of metalcomplexes based on triazine derivatives have been studied for their interesting magnetic [27,28,29] and catalytic [30,31,32,33,34,35,36,37,38,39,40,41] applications.Among the s-triazine derivatives, 2,4-bis(3,5-dimethyl-1H-pyrazol-1-yl)-6-methoxy-1,3,5-triazine (MBPT) pincer ligand has been extensively used in the synthesis of a wide range of homoleptic and heterolepticmetal(II)complexes with coordination numbers ranging from five to eight [42,43,44,45,46,47,48,49,50]. Recently, we reported that the reaction of MBPT with CoCl2 afforded the [Co(MBPT)Cl(H2O)2]Cl pincer complex, which was found to be the best candidate as an antimicrobial agent compared to the [Co(MBPT)(NO3)2] and [Co(MBPT)(H2O)3](ClO4)2 analogues [48]. Furthermore, a number of [ML]Cl2 and [ML2]Cl2complexes (where M = Cu(II), Ni(II), and Co(II), and L is 2,4-bis(3,5-dimethyl-1H-pyrazol-1-yl)-6-phenylamino-1,3,5-triazine) were synthesized and were also investigated for their antimicrobial activities [51]. Following the research on the same class of these pincer ligands, we present here the self-assembly of the s-triazine functionalligands shown in Figure 1 with CoCl2 in order to synthesize new biologically active complexes bearing both bioactive species; the ligand and Co(II) ion, which could lead to the synthesis of powerful antimicrobial agents. The structural aspects of the synthesized complexes were analyzed using single-crystal X-ray diffraction, Hirshfeld, and DFT calculations, as well as spectroscopic analysis. In addition, the antimicrobial and antioxidant activities of both complexes were examined and compared with the free ligands.
Figure 1
Structure of the pincer ligands.
2. Results and Discussion
2.1. Chemistry
The self-assembly of the functionalligands 4-(4,6-bis(3,5-dimethyl-1H-pyrazol-1-yl)-1,3,5-triazin-2-yl)morpholine () and 2,4-bis(3,5-dimethyl-1H-pyrazol-1-yl)-6-(piperidin-1-yl)-1,3,5-triazine () with CoCl2 in methanol afforded the corresponding heteroleptic neutralcomplexes [Co( and [Co( in good yield. The Structure aspects of complexes 1 and 2 were analyzed using different spectroscopic tools such as FTIR, UV-Vis, and low-temperature X-ray single-crystal diffraction combined with Hirshfeld calculations. Crystallographic details are listed in Table 1. In addition, biological evaluations of these new complexes as antimicrobial and antioxidant agents were performed and compared with the corresponding free ligands.
Table 1
Crystal data and structure refinement for the studied complexes.
Compound
[Co(MorphBPT)Cl2] (1)
[Co(pipBPT)Cl2] (2)
Empirical formula
C17 H22 Cl2 Co N8 O
C18 H24 Cl2 Co N8
Formula weight
484.25 g/mol
482.28 g/mol
Temperature
121(2) K
121(2) K
Wavelength
0.71073 Å
0.71073 Å
Crystal system
Monoclinic
Triclinic
Space group
C2/c
P-1
Unit cell dimensions
a = 17.241(5) Å
a = 11.094(3) Å
b = 12.832(3) Å
b = 12.785(3) Å
c = 20.165(7) Å
c = 16.527(4) Å
α = 90°
α = 97.125(6)°
β = 109.687(9)°
β = 103.496(6)°
γ = 90°
γ = 102.933(6)°
Volume
4200.(2) Å3
2182.8(10) Å3
Z
8
4
Density (calculated)
1.531 g/cm3
1.468 g/cm3
Absorption coefficient
1.098 mm−1
1.053 mm−1
F(000)
1992
996
Crystal size
0.14 × 0.21 × 0.25 mm3
0.20 × 0.27 × 0.32 mm3
Theta range for data collection
2.51 to 25.34°
2.21 to 25.32°
Index ranges
−20 ≤ h ≤ 20
−13 ≤ h ≤ 13
−15 ≤ k ≤ 13
−15 ≤ k ≤ 15
−24 ≤ l ≤ 24
−19 ≤ l ≤ 19
Reflections collected
14,323
35,520
Independent reflections
3834 [R(int) = 0.0293]
7949 [R(int) = 0.0373]
Completeness to theta
99.60%
99.70%
Refinement method
Full-matrix least-squares on F2
Data/restraints/parameters
3834/0/267
7949/0/532
Goodness-of-fit on F2
1.033
1.041
Final R indices (I > 2sigma(I))
R1 = 0.0250, wR2 = 0.0581
R1 = 0.0246, wR2 = 0.0548
R indices (all data)
R1 = 0.0310, wR2 = 0.0616
R1 = 0.0324, wR2 = 0.0584
Extinction coefficient
0.00125(12)
0.0036(3)
Largest difference peak and hole
0.342 and −0.353
0.315 and −0.272
CCDC
20805833
20805834
2.1.1. Structure Description of [Co( (1)
The neutralcomplex [Co( (1) crystallized in the monocliniccrystal system and the centrosymmetricC2/c space group. The asymmetric unit comprised one [Co( with Z = 8. The structure of 1 revealed a penta-coordinated Co(II)complex with one tridentate chelate and two chloride anionicligands in the inner sphere (Figure 2; right part). The ligand coordinated the Co(II) via one short Co-N( and relatively longer Co-N(pyrazole) bonds. The corresponding Co1-N1, Co1-N4, and Co1-N6 distances are 2.0387(15), 2.2008(15), and 2.2304(16) Å, respectively. The two Co-Cl distances are very similar, where the Co1-Cl1 and Co1-Cl2 distances are 2.2718(7) and 2.2968(7) Å, respectively. The bite angles in the coordinated are 74.01(6) and 73.07(5)° for N1-Co1-N4 and N1-Co1-N6, respectively, while the N4-Co1-N6 and Cl2-Co1-Cl1 bond angles are 146.87(5) and 111.40(3)°, respectively (Table 2). The ring systems in are not perfectly coplanar where the angle between the s-triazine mean plane and each of the two pyrazolyl rings are 4.88 and 8.49° for the pyrazole moieties with lower and higher atom numbering, respectively. The distortion in the CoN3Cl2coordination sphere of complex 1 was described using the criterion reported by Addison [52]. The geometry around Co(II) is a distorted square pyramidal with N4-Co1-N6 (β= of 146.87(5)°) and N1-Co1-Cl2 (α = 138.89(4)°), giving a τ value of 0.133. The distorted square pyramidalconfiguration comprised Cl2N1N4N6 donor atoms in the basal plane and Cl1 as apical (Figure 2; left part).
Figure 2
Structure with atom numbering (left) and the distorted square pyramidal (right) of 1.
Table 2
Bond lengths (Å) and angles (°) for complexes 1 and 2.
[Co(MorphBPT)Cl2] (1)
[Co(PipBPT)Cl2] (2)
Co1-N1
2.0387(15)
Co1-N1
2.0291(15)
Co1A-N1A
2.0325(15)
Co1-N4
2.2008(15)
Co1-N4
2.1829(15)
Co1A-N4A
2.2023(15)
Co1-N6
2.2304(16)
Co1-N6
2.1935(15)
Co1A-N6A
2.2184(15)
Co1-Cl2
2.2718(7)
Co1-Cl2
2.2766(7)
Co1A-Cl2A
2.2667(6)
Co1-Cl1
2.2968(7)
Cl1-Co1
2.2822(7)
Co1A-Cl1A
2.2686(8)
N1-Co1-N4
74.01(6)
N1-Co1-N4
73.73(6)
N1A-Co1A-N4A
73.83(6)
N1-Co1-N6
73.07(5)
N1-Co1-N6
74.23(6)
N1A-Co1A-N6A
73.72(6)
N4-Co1-N6
146.87(5)
N4-Co1-N6
147.94(5)
N4A-Co1A-N6A
147.43(5)
N1-Co1-Cl2
138.89(4)
N1-Co1-Cl2
119.81(4)
N1A-Co1A-Cl2A
115.61(5)
N4-Co1-Cl2
102.34(4)
N4-Co1-Cl2
97.95(4)
N4A-Co1A-Cl2A
100.41(4)
N6-Co1-Cl2
99.89(4)
N6-Co1-Cl2
98.88(4)
N6A-Co1A-Cl2A
95.97(4)
N1-Co1-Cl1
109.63(5)
N1-Co1-Cl1
122.66(4)
N1A-Co1A-Cl1A
124.96(4)
N4-Co1-Cl1
97.96(4)
N4-Co1-Cl1
100.29(4)
N4A-Co1A-Cl1A
95.76(4)
N6-Co1-Cl1
96.42(4)
N6-Co1-Cl1
95.81(4)
N6A-Co1A-Cl1A
100.40(4)
Cl2-Co1-Cl1
111.40(3)
Cl2-Co1-Cl1
117.51(2)
Cl2A-Co1A-Cl1A
119.43(2)
The packing of complex molecules in 1 is controlled by O1…H11 and Cl1…H6 contacts shown in Figure 3 (upper part). The donor (D)-acceptor (A) distances are 3.503(3) and 3.550(2) Å for O1…H11 and Cl1…H6 hydrogen bond contacts, respectively (Table 3). Packing of complex units via C-H…Cl and C-H…O interactions is shown in Figure 3 (lower part).
Figure 3
The hydrogen bond contacts (upper) and hydrogen bonding network (lower) in 1.
Table 3
Geometric parameters of the hydrogen bonds [Å and °] in complexes 1 and 2.
1
C6-H6…Cl1 i
0.95
2.65
3.550(2)
158
C11-H11…O1 ii
0.95
2.58
3.503(3)
165
i 1/2-x,-1/2+y,3/2-z; ii 1/2+x,3/2-y,1/2+z
2
C6A-H6A…Cl2 i
0.95
2.74
3.524(2)
140
C8-H8A…Cl2 ii
0.98
2.82
3.768(2)
162
C13-H13A…Cl2 iii
0.98
2.76
3.611(2)
146
i 1+x,y,z; ii -x,-y,1-z; iii 1-x,1-y,1-z.
2.1.2. Structure Description of [Co( (2)
The [Co( complex (2) crystallized in the less symmetric tricliniccrystal system and P-1 space group with Z = 4 and two molecular units as an asymmetric formula. In both units, the Co(II) is penta-coordinated with CoN3Cl2coordination sphere comprising one ligand chelating the Co(II) ion in a pincer fashion augmented with two Co-Cl bonds at almost equal distances (Figure 4). Generally, the bond distances and angles of the two asymmetric formulas are very similar (Table 2). The τ values are 0.42 and 0.37 for the two molecular units I and II of [Co( complex indicating more distorted square pyramidalcompared to complex 1. It could be considered as an intermediate structure between square pyramidal and trigonal bipyramidalconfigurations. For molecule I, the angle between the s-triazine mean plane and each of the two pyrazolyl rings are 4.17 and 0.69° for the pyrazole moieties with lower and higher atom numbering, respectively. On the other hand, for molecule II the corresponding values are 4.71 and 7.76°, respectively.
Figure 4
Structure with atom numbering (upper) and the distorted square pyramidal (lower) of 2.
The packing of complex molecules in 2 is controlled by Cl2…H6A, Cl2…H8A, and Cl2…H13Acontacts shown in Figure 5 (upper part). The donor (D)-acceptor (A) distances are 3.524(2), 3.768(2) and 3.611(2) Å, respectively (Table 3). The hydrogen-bonding network in which the complex units are interconnected via C-H…Cl interactions as shown in Figure 5 (lower part).
Figure 5
The hydrogen bond contacts (upper) and hydrogen bonding network (lower) in 2.
2.2. Hirshfeld Topology Analyses
In order to further explore the different intermolecular contacts in the solid-state structure of the studied complexes, we employed Hirshfeld calculations (Figures S1–S3; Supplementary Data). Quantitative analysis results of all possible interactions are presented in Figure 6.
Figure 6
The important contacts and their percentages.
The percentages of the H…H contacts are 48.8% and 47.7–56.1% from the whole contacts detected in [Co( and [Co(, respectively, while the Cl…H contact percentages are 17.4 and 18.9–22.5%, respectively. It is clear from the decomposed fingerprint and dnorm maps that these interactions have the characteristics of short contacts (Figure 7 and Figure 8). The shortest intermolecular contacts are listed in Table 4. In complex 1, the packing is controlled by O…H and Cl…H hydrogen bonds as well as C-H…π and Cl…C (anion-π stacking) interactions. The latter belongs to the interaction between the coordinated chloride anion Cl2 and the C1 atom from the electron-deficient s-triazine moiety. In complex 2, the packing is also dominated by short Cl…H, C-H…π and Cl…C (anion-π stacking) interactions. It is noted that the Cl2…C1 (3.297 Å) in complex 1 is significantly shorter than the Cl2A…C3 (3.407 Å) and Cl2A…C2 (3.412 Å) interactions in complex 2. The H…C(π-system) are in the range of 2.642–2.751 and 2.722–2.727 Å in complexes 1 and 2, respectively. Also, the C…C/C…Ncontacts having longer distances than the vdWs radii sum of the interacting elements indicated weak π-π interactions.
Figure 7
Hirshfeld surfaces of complex 1.
Figure 8
Hirshfeld surfaces of complex 2.
Table 4
The most important contacts in complexes 1 and 2.
1
2
Contact
Distance
Contact
Distance
C6…H14B
2.745
C5A…H16D
2.727
C7…H14B
2.642
C10A…H17A
2.722
C8…H14B
2.718
Cl2A…C3
3.407
C3…H4A
2.751
Cl2A…C2
3.412
Cl2…C1
3.297
Cl2…H6A
2.642
Cl1…H6
2.527
Cl1A…H4C
2.780
O1…H11
2.447
Cl2A…H4A
2.797
H4C…H15A
2.223
Cl2…H13A
2.670
C6…C2
3.495
Cl2…H8A
2.724
C6…N7
3.390
Cl1...H18B
2.816
H9A…H13B
2.294
C11…N4A
3.347
C11…N5A
3.341
N2…H8B
2.578
2.3. FTIR Spectra
The FTIR spectra of [Co( (1) and [Co( (2) showed some variations compared to the free ligands. The free and showed the C=N stretching modes at 1609 and 1603 cm−1, respectively. The corresponding values in complexes 1 and 2 showed significant shifts toward higher wavenumbers of 1633 and 1636 cm−1, respectively, due to the coordination of the Co(II) with the pincer ligand. Additionally, the νC = C modes in the free ligands were observed at 1529 and 1512 cm−1 for and , respectively. The νC = C modes are also significantly shifted to higher wave numbers of 1589 and 1597 cm−1 in [Co( (1) and [Co( (2), respectively. The presentation of the calculated vibrational spectra of complex 2 compared with the experimental FTIR spectra is shown in Figure 9. The results indicated two sharp bands at 1670.7 and 1558.1 cm−1 with relatively high intensity corresponding to the mixed C=N and C=C stretching vibrations. A comprehensive comparison of the experimental and calculated vibrationalcharacteristics for complex 2 is provided in Table S1 (Supplementary Data). Generally, the calculated results are in fair agreement with the experimental results. For example, the calculated aromatic νC-H modes of the pyrazolyl moiety are calculated at 3272.4 cm−1 (exp. 3114.5 cm−1) while the asymmetric and symmetric aliphatic νC-H modes are calculated at 3146.7 cm−1 (exp. 2931.9 cm−1) and 3089.3–3021.0 cm−1 (exp. 2856.9 cm−1), respectively. The overestimations of the calculated vibrational frequencies compared to the experimental results are expected since the calculation was performed for a single molecule in the gas phase and hence neglects the anharmonicity present in the real system.
Figure 9
The experimental (upper) and calculated (lower) vibrational spectra of complex 2.
2.4. Electronic Spectra
The electronic spectra of 4 × 10−3 M solution of complex 2 were recorded in ethanol as solvent. The experimentally observed UV-Vis spectra along with the simulated electronic spectra calculated using the TD-DFT method for complex 2 are shown in Figure 10. The recorded electronic spectra showed a broad spectral band at 564 nm, which was calculated at 589.9 nm.
Figure 10
The experimental (left) and calculated (right) electronic spectra of complex 2.
In order to assign the origin of this electronic spectral band, the calculated excited and ground states included in this spectral band are shown in Figure 11. The band observed in the visible region could be assigned to electronic transitions from HOMO, HOMO-1, HOMO-9, and HOMO-10 as ground states to LUMO+4 as an excited state where all are β-type orbitals. This electronic transition could be described as mainly metal-ligand () charge transfer-based transition.
Figure 11
Origin of the electronic spectral band observed in ethanol for complex 2.
2.5. Antimicrobial Activity
The biological activity of the free ligands ( and ), as well as the Co(II)complexes [Co( (1) and [Co( (2), were evaluated against S. aureus and B. subtilis as Gram-positive bacteria, E. coli and P. vulgaris as Gram-negative bacteria and two fungi (A. fumigatus and C. albicans). Minimum inhibition zone diameters were determined for the studied compounds (10 mg/mL) and the results are listed in Table 5.
Table 5
Inhibition zone diameters of the studied compounds and control against different microbes a.
Micorbe
MorphBPT
1
PipBPT
2
Control
A. fumigatus
-
-
-
-
17 a
C. albicans
-
-
-
-
20 a
S. aureus
-
20
-
18
25 b
B. subtilis
-
24
13
26
27 b
E. coli
-
16
-
15
30 b
P. vulgaris
-
-
-
30
27 b
a Ketoconazole and b Gentamycin.
The results shown in Table 5 indicated that the free ligands have no antimicrobial activity against all the studied microbes at the applied concentration (10 mg/mL) except which is active only against the Gram-positive bacteria B. subtilis (13 mm). In contrast, the Co(II)complexes showed interesting antibacterial activities. Complex 1 is active against the two tested Gram-positive bacteria (S. aureus (20 mm) and B. subtilis (24 mm)) and one Gram-negative bacteria (E. coli (16 mm)). On the other hand, complex 2 showed significant antibacterial activities against all the studied bacteria strains with inhibition zone diameters ranging from 15 mm (E. coli) to 30 mm (P. vulgaris). An additional observation that could be concluded from these results; complex 2 has better antibacterial activity against P. vulgaris (30 mm) and very close antibacterial activities against B. subtilis (26 mm) compared to control (gentamycin: 27 mm). Both complexes showed no antifungal activity against the two tested fungi at the experimentalconditions. The results indicated that the synthesized Co(II)complexes are promising antibacterial agents rather than antifungal agents.Moreover, the minimum inhibitory concentrations (MIC) in μg/mL were determined and the results are depicted in Table 6. The results are in accord with our observations. The MIC values are the lowest for complex 2 against B. subtilis, P. vulgaris, and S. aureus indicated potent activities against these microbes. It is also more potent (complex 2; 39 μg/mL) than against B. subtilis (87 μg/mL). Complex 1 has lower potency against the studied bacteria with higher MIC values ranging from 156–625 μg/mL.
Table 6
MIC values (μg/mL) for the studied compounds.
Micorbe
MorphBPT
1
PipBPT
2
A. fumigatus
-
-
-
-
C. albicans
-
-
-
-
S. aureus
-
156
-
20
B. subtilis
-
312
78
39
E. coli
-
625
-
1250
P. vulgaris
-
-
-
20
2.6. Antioxidant Activity
The DPPH free radical scavenging assay enabled us to determine the antioxidant activity of the studied complexes compared to the free ligands. The detailed results are tabulated in Tables S2–S5 (Supplementary Data) and summarized graphically in Figure 12. Although the results showed that the studied systems have weak to moderate antioxidant activity, especially for the free ligands and complex 2, but the most significant conclusion is that complex 1 has improved antioxidant activity compared to the free ligand while the antioxidant activity of and its [Co(; 2 are comparable indicating that varying the substituent at the s-triazinecore of the functionalligand have a significant impact on the antioxidant activity of this class of Co(II)complexes.
Figure 12
The antioxidant activity of the studied compounds.
3. Materials and Methods
Chemicals were purchased from Sigma-Aldrich Company (Chemie GmbH, 82024 Taufkirchen, Germany). The CHN analyses were determined using a Perkin-Elmer 2400 instrument (PerkinElmer, Inc., 940 Winter Street, Waltham, MA, USA). Cobaltcontent was determined using Shimadzu atomic absorption spectrophotometer (AA-7000 series, Shimadzu, Ltd., Kyoto, Japan). An Alpha Bruker spectrophotometer (Billerica, MA, USA) was used to measure the FTIR spectra in KBr pellets (Figures S4 and S5, Supplementary Data). The FTIR spectra were recorded in the range of 4000–400 cm−1 at a spectral resolution of 2 cm−1 and with 40 scans. The UV-Vis electronic spectra were recorded in ethanol using Pg instruments T80+ spectrophotometer (Alma Park, Wibtoft, UK). The melting points were ascertained in open capillary tubes using a Gallenkamp melting point apparatus (Sigma-Aldrich Chemie GmbH, Taufkirchen, Germany) and were uncorrected.
3.1. Syntheses of [Co(; (1) and [Co(; (2)
The ligands were prepared following the same method reported by us [53]. Details regarding the ligand preparations were given in (Supplementary Material Method S1, Figures S6 and S7).A 10 mL methanolic solution of 0.5 mmol of the functionals-triazinechelate was added to 10 mL aqueous solution of the CoCl2 (64.9 mg, 0.5 mmol). Purple color crystals of the titled complexes were obtained after five days.Yield; C17H22Cl2CoN8O (1) 86%; mp > 360 °C (dec). Anal. Calc. C, 42.16; H, 4.58; N, 23.14; Co, 12.17%. Found: C, 41.93; H, 4.49; N, 23.01; Co, 12.05%. IR (KBr, cm−1): 3090, 2983, 2924, 2859, 1633, 1589, 1499, 1448, 1067, 1020.Yield; C18H24Cl2CoN8 (2) 81%; mp > 360 °C (dec). Anal. Calc. C, 44.83; H, 5.02; N, 23.23; Co, 12.22%. Found: C, 44.98; H, 4.94; N, 23.09; Co, 12.10%. IR (KBr, cm−1): 3115, 2932, 2857, 1636, 1597, 1493, 1444, 1041, 1008.
3.2. Crystal Structure Determination
A Bruker D8 Quest diffractometer was used to determine the crystal structures of complexes 1–2 with the aid of SHELXTL and SADABS programs [54,55,56]. Refinement and crystal details were given in Table 1. Hirshfeld calculations were performed using the Crystal Explorer 17.5 program [57,58,59,60,61,62].
3.3. Antimicrobial Studies
The antimicrobial activity of the free BPT and ligands, as well as the corresponding Co(II)complexes, against two Gram-positive bacteria (S. aureus (ATCC 25923) and B. subtilis (RCMB015(1)NRR LB-543)), two Gram-negative bacteria (E. coli (ATCC 25922) and P. vulgaris (RCMB 004(1)ATCC 13315)), and two fungi (A. fumigatus (RCMB 002008) and C. albicans (RCMB 005003(1) ATCC 10231)). Minimum inhibition zone diameters at 10 mg/mL of the studied compounds, as well as the minimum inhibitory concentrations (MIC), were determined against these microbes [53]. Gentamycin and ketoconazole were used as standard antibacterial and antifungal agents, respectively. More details are found in (Method S2 Supplementary Data).
3.4. Antioxidant Activity
The antioxidant activity of complexes 1 and 2 was determined at the RegionalCenter for Mycology and Biotechnology (RCMB) at the Al-Azhar University by the DPPH free radical scavenging assay in triplicate and average values were considered [63,64]. More details regarding the bio-experiments are found in (Method S3 Supplementary Data).
3.5. DFT Calculations
The structure of complex 2 was optimized in the gas phase using the B3LYP method employing 6–31G(d,p) for nonmetal atoms and LANL2DZ for Co [65] with the aid of Gaussian 09 software [66]. All frequency results are positive and no imaginary frequency indicating real minima. The gas-phase optimized structure was used as the input for simulating the structure in ethanol as solvent followed by TD-DFT calculations in the same solvent in order to simulate and assign the experimentally observed UV-Vis spectra [67,68].
4. Conclusions
Two penta-coordinated Co(II)complexes with bis-pyrazolo-s-triazine pincer ligands bearing morpholino () and piperidino () substituents were synthesized and their structure aspects were analyzed using single-crystal X-ray diffraction and Hirshfeld analysis. The mononuclear [Co(; 1 and [Co(; 2 pincer complexes have a similar coordination environment comprising a tridentate functionalligand and two coordinated chloride ions. Complex 2 has higher potency against all the studied bacteria (except E. coli) than complex 1. In addition, the antioxidant activity of complex 1 is higher than while both 2 and have comparable results. These outcomes shed light on the importance of the nature of the substituent on the s-triazine ring of the coordinated functionalligand on the antioxidant activity. The design of s-triazineligands carrying different substituents could improve the antioxidant activity, which is one of our future perspectives.
Authors: N P Jensen; A L Ager; R A Bliss; C J Canfield; B M Kotecka; K H Rieckmann; J Terpinski; D P Jacobus Journal: J Med Chem Date: 2001-11-08 Impact factor: 7.446
Authors: Rahul V Patel; Premlata Kumari; Dhanji P Rajani; Christophe Pannecouque; Erik De Clercq; Kishor H Chikhalia Journal: Future Med Chem Date: 2012-06 Impact factor: 3.808
Authors: Brad R Henke; Thomas G Consler; Ning Go; Ron L Hale; Dana R Hohman; Stacey A Jones; Amy T Lu; Linda B Moore; John T Moore; Lisa A Orband-Miller; R Graham Robinett; Jean Shearin; Paul K Spearing; Eugene L Stewart; Philip S Turnbull; Susan L Weaver; Shawn P Williams; G Bruce Wisely; Millard H Lambert Journal: J Med Chem Date: 2002-12-05 Impact factor: 7.446
Authors: Rita Menicagli; Simona Samaritani; Giovanni Signore; Francesca Vaglini; Lisa Dalla Via Journal: J Med Chem Date: 2004-09-09 Impact factor: 7.446